Entremed (ENMD)

[georgejjl]

Cycle Dude

I agree with C_Peptide that the Gina Kolata article in the New York times was the cause of the 1997 "moon shot". ENMD stock closed that Friday at about $12 per share on the Monday following the article ENMD traded as high as $85 per share. I had a limit order in before the market opened at $17 per share. It never traded that low on that day.

What you have to remember is that that "moon shot" was the result of an article about experiments on mice.

Think about what could happen if and/or when an article about the Panzem NCD trials are published with outstandingly good results in human trials. The Panzem NCD trials are scheduled to start early in 2005 and I expect that they will be seeing outstandingly good results within three months from the start of the trial based on everything that I have read.

Good luck and God bless,

George